Credit: Endo, Inc At this time, there have been no reports of adverse events related to this recall. While the blister strips ...

G400 Localization-related (focal) (partial) idiopathic epilepsy and epileptic syndromes with seizures of localized onset G4000 Localization-related (focal) (partial) idiopathic epilepsy and ...

Seventy-six items achieved consensus, including indications for LDOM versus topical minoxidil, dosing for adults and teens, contraindications ...

(HealthDay News) — Glucagon-like peptide-1 receptor agonist (GLP-1 RA) use may reduce alcohol consumption and improve outcomes in some individuals, according to a study published online Nov. 14 in ...

Miplyffa was approved in September 2024 based on data from a clinical trial that showed arimoclomol plus miglustat slowed NPC disease progression.

The BLA approval is supported by data from the COBLT study, FDA dockets and public information, and from a RegeneCyte observational database.

F19122 Other psychoactive substance abuse with intoxication with perceptual disturbances F19129 Other psychoactive substance abuse with intoxication, unspecified F1913 Other psychoactive substance ...

Maternal vaccination two to three or three to four weeks before delivery linked to lower cord:maternal transfer ratios versus at least five weeks ...